Biotechnology Get all the latest news from the field of biotechnology including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance and market analysis.

Latest Biotechnology

13:00 BST GenePOC® Launches its GenePOC® CDiff Test in Canada

GenePOC announces the Health Canada approval and launch of its molecular diagnostic test for the detection of Clostridium difficile in Canada...


12:30 BST Anadolu Medical Center is First in Turkey to Install Accuray Radixact® System

Distinguished Center Chooses Radixact Technology to Expand Range of Cancer Treatment Options, Raising the Bar for Other Centers Providing...


12:00 BST Alkermes Plc Reports Third Quarter 2018 Financial Results

— Third Quarter Revenues Increased to $248.7 Million, Driven by 24% Year-Over-Year Growth of Proprietary Product Net Sales — — Company Reports...


12:00 BST CROMSOURCE Appoints Director of Regulatory Services and Expands Regulatory Operations

CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical,...


11:25 BST Collagen Market is Expected to Grow at a CAGR of 7.63% by 2022, Owing to the Increasing Demand for Collagen Based Products in Medical Applications: Radiant Insights, Inc.

Global Collagen Market is expected to grow at a CAGR of 7.63% during the period 2018-2022, owing to the increasing demand for collagen based...


07:36 BST Cyxone Selects First Clinical Site Ahead of Phase 1 Study With T20K in MS

Cyxone AB (publ) announced today that the company has selected the clinical site that will carry out the drug candidate T20K's first in man study....


07:00 BST Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn's Disease

EB8018, the lead investigational candidate, targets Crohn's disease with potential for other GI disorders ENTEROME SA, a clinical-stage biotech...


22 Oct, 2018, 12:00 BST In-vitro Fertilization Market to Gain Strength From Rising Awareness About Male Infertility and Medical Tourism in Developing Economies, Says TMR

The global in-vitro fertilization market estimated valuation was US$529.8 million in 2017. Expanding at a promising CAGR of 6.5% from 2017 to...


22 Oct, 2018, 11:45 BST New real-world evidence confirms utility of the Oncotype DX® test in clinical practice for patients with early-stage breast cancer

- Further demonstrates the test's ability to change clinical chemotherapy treatment decisions by more precisely identifying patients who will or...


22 Oct, 2018, 11:30 BST PLENVU® (NER1006) the First 1 Litre Bowel Preparation to Show Superior High-quality Segmental Cleansing of the Colon Compared to Standard of Care[I]

Norgine B.V. today presented new data at the United European Gastroenterology Week which show that for the first time, PLENVU® (polyethylene...


22 Oct, 2018, 11:00 BST Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer

The Australian oncology-focused biotech Kazia Therapeutics announced today that it will collaborate with world-leading treatment and research...


22 Oct, 2018, 08:00 BST SeraCare Announces Launch of Expanded NTRK Reference Material Panel

An important new tool for labs seeking to detect NTRK gene fusions by next-generation sequencing SeraCare Life Sciences, a manufacturer and...


22 Oct, 2018, 07:30 BST Oxurion NV Extends Partnership with Retina Global in Support of Bolivian Diabetic Retinopathy (BOLDR) Project

Oxurion NV (Euronext Brussels: OXUR - formerly known as ThromboGenics), a biopharmaceutical company developing innovative treatments to preserve...


22 Oct, 2018, 07:00 BST Anaeropharma Science Signs Collaborative Research Agreement with Chugai on Creation of Novel Oncology Drugs Using Bifidobacterium

Anaeropharma Science Inc. headquartered in Tokyo (hereinafter "Anaeropharma") announced on October 22 that Anaeropharma Science and Chugai...


22 Oct, 2018, 06:18 BST BerGenBio Announces Interim Biomarker and Phase II Clinical Data With Selective AXL Inhibitor Bemcentinib Presented at ESMO

Biomarker predicts clinical benefit rate of 70% and overall response rate of 40% in second line NSCLC Melanoma combination study reports safety...


22 Oct, 2018, 01:00 BST Veeda Clinical Research Scores Another Perfect NPRA (Malaysian Regulatory Agency) Audit

Veeda Clinical Research Pvt. Ltd., a leading independent CRO is proud to announce that our clinical (Shivalik, Ahmedabad)and Bio analytical...


21 Oct, 2018, 13:59 BST BioArctic is Granted a Concept Patent in Europe for the Company's Strategy for Disease-modifying Treatment of Parkinson's Disease

BioArctic AB (publ) (Nasdaq Stockholm: BIOA-B) announced today that the European Patent Office (EPO) has issued a decision to grant the company's...


20 Oct, 2018, 14:04 BST Cantargia Presented Positive Phase I Clinical Data with Lead Candidate CAN04 at ESMO

The antibody CAN04 was well tolerated and 6 mg/kg is a safe dose - Effects on biomarkers and 5 of 13 evaluable patients achieved stable...


19 Oct, 2018, 23:59 BST BERG to Present New Data Describing Details on Progress of its Oncology Portfolio and Precision Medicine Applications at the European Society for Medical Oncology 2018 Congress

BERG LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the...


19 Oct, 2018, 18:10 BST Mylan Launches Hulio™ (Biosimilar Adalimumab) in Markets Across Europe

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it has initiated the commercial launch of Hulio™, a biosimilar to...


19 Oct, 2018, 12:00 BST Veeda Clinical Research Scores Another Perfect NPRA (Malaysian Regulatory Agency) Audit

Veeda Clinical Research Pvt. Ltd., a leading independent CRO is proud to announce that our clinical (Shivalik, Ahmedabad)and Bio analytical...


19 Oct, 2018, 08:30 BST Don't Miss the Signs of a Breaking Spine, Warns IOF

Osteoporosis, a disease which causes bones to become weak and fragile, is the cause of broken bones in approximately one in three women and one...


19 Oct, 2018, 07:38 BST InDex Pharmaceuticals Publishes Post-hoc Analysis of the COLLECT Study

InDex Pharmaceuticals Holding AB (publ) today announced the publication of a post-hoc analysis of COLLECT study data. COLLECT was a clinical study...


19 Oct, 2018, 07:12 BST Arix Bioscience plc: LogicBio Prices Nasdaq IPO

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATION NO.596/2014 - Third public listing...


19 Oct, 2018, 07:00 BST Norgine to Present Data for Plenvu® and Xifaxan® at the United European Gastroenterology Week

- Seven PLENVU® related posters - one poster demonstrating PLENVU® higher efficacy compared to standard of care - Three XIFAXAN®...